Cargando…

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function

INTRODUCTION: Plasminogen activator inhibitor-1 (PAI-1), a major inhibitor of fibrinolysis, is associated with thrombosis, obesity, insulin resistance, dyslipidemia, and premature aging, which all are coexisting conditions of chronic obstructive pulmonary disease (COPD). The role of PAI-1 in COPD wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waschki, Benjamin, Watz, Henrik, Holz, Olaf, Magnussen, Helgo, Olejnicka, Beata, Welte, Tobias, Rabe, Klaus F, Janciauskiene, Sabina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367764/ https://www.ncbi.nlm.nih.gov/pubmed/28356730 http://dx.doi.org/10.2147/COPD.S128689

Ejemplares similares

Angiopoietin-like protein 4 and cardiovascular function in COPD
por: Waschki, B, et al.
Publicado: (2016)

Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity
por: Cockayne, Debra A., et al.
Publicado: (2012)

Cardiovascular predictors of mortality and exacerbations in patients with COPD
por: Alter, Peter, et al.
Publicado: (2022)

Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis
por: Bahmer, Thomas, et al.
Publicado: (2017)

Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD
por: Holz, Olaf, et al.
Publicado: (2014)

Rating sputum cell quality in clinical trials for asthma and COPD treatment
por: Pedersen, Frauke, et al.
Publicado: (2019)

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions
por: Janciauskiene, Sabina, et al.
Publicado: (2018)

The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
por: Sark, Annelot D., et al.
Publicado: (2022)

Editorial: Acute phase proteins as biomarkers and therapeutics in acute and chronic inflammatory conditions
por: Stanke, Frauke, et al.
Publicado: (2023)

A Novel Mouse Monoclonal Antibody C42 against C-Terminal Peptide of Alpha-1-Antitrypsin
por: Tumpara, Srinu, et al.
Publicado: (2021)

Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant
por: Pedersen, Frauke, et al.
Publicado: (2021)

Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-controlled study
por: Watz, Henrik, et al.
Publicado: (2014)

Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial
por: Watz, Henrik, et al.
Publicado: (2018)

Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial
por: Beeh, Kai M, et al.
Publicado: (2014)

Diagnostic outcome of two different CT-guided fine needle biopsy procedures
por: Welker, Lutz, et al.
Publicado: (2007)

Indirect effect of alpha-1-antitrypsin on endotoxin-induced IL-1β secretion from human PBMCs
por: Janciauskiene, Sabina, et al.
Publicado: (2022)

Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET
por: Kellerer, Christina, et al.
Publicado: (2021)

Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline
por: Ferguson, Gary T, et al.
Publicado: (2020)

Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin †
por: Tumpara, Srinu, et al.
Publicado: (2021)

Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD
por: Holz, Olaf, et al.
Publicado: (2015)

The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET
por: Kahnert, K., et al.
Publicado: (2020)

Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2023)

Beneficial effects of alpha-1 antitrypsin therapy in a mouse model of colitis-associated colon cancer
por: Al-Omari, Mariam, et al.
Publicado: (2023)

Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort
por: Lutter, Johanna I, et al.
Publicado: (2020)

Plasma markers of COVID-19 severity: a pilot study
por: Beimdiek, Julia, et al.
Publicado: (2022)

Human PBMCs Form Lipid Droplets in Response to Spike Proteins
por: Sivaraman, Kokilavani, et al.
Publicado: (2023)

Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
por: Kahnert, Kathrin, et al.
Publicado: (2022)

Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort
por: Holz, Olaf, et al.
Publicado: (2021)

Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
por: Carleo, Alfonso, et al.
Publicado: (2017)

Cardiovascular disease and COPD: dangerous liaisons?
por: Rabe, Klaus F., et al.
Publicado: (2018)

Anti-inflammatory effects of budesonide in human lung fibroblast are independent of histone deacetylase 2
por: Wang, Xingqi, et al.
Publicado: (2013)

Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomyomatosis (LAM) compared with COPD – a retrospective analysis
por: Gloeckl, Rainer, et al.
Publicado: (2020)

Association of Airway Eosinophilia with Small Airway Dysfunction in Patients with Mild and at Risk for COPD
por: Abdo, Mustafa, et al.
Publicado: (2022)

IgE is associated with exacerbations and lung function decline in COPD
por: Lommatzsch, Marek, et al.
Publicado: (2022)

Assessing airway inflammation in clinical practice – experience with spontaneous sputum analysis
por: Holz, Olaf, et al.
Publicado: (2008)

Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease
por: Rodriguez-Roisin, Roberto, et al.
Publicado: (2016)

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2019)

Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD
por: Watz, Henrik, et al.
Publicado: (2018)

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
por: Alter, Peter, et al.
Publicado: (2022)

Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD
por: Alter, Peter, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5qq9trnfuotgtf1id1gmvrlenb